Blog - Page 1217 of 5708

TuesdaySep 14, 2021 9:03 am

SRAX Inc. (NASDAQ: SRAX) Gears up for Its First Ever 2021 Sequire EdTech Conference, Announces EdTech Heavyweights as Keynote Speakers

2021 Sequire EdTech Conference announces keynote speaker lineup and agenda featuring founders and leaders of EdTech big names such as Udemy, HolonIQ, Amesite, and more Online education and remote work sector have exploded over the past years, attracting growing attention from investors Conference aims to bring this growing sector closer to diverse investor audiences, including institutional and retail investors, family offices, venture capitalists and private equity firms, and public and emerging growth companies SRAX (NASDAQ: SRAX), a financial technology company that developed Sequire, a SaaS platform designed to unlock data and insights for publicly traded companies, has announced an impressive…

MondaySep 13, 2021 3:27 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Poised to Offer Solution to Rising Challenge Facing Global Health Systems

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more…

MondaySep 13, 2021 3:17 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Achieves Significant YOY Increases in Revenue, Gross Profits

AmpliTech Group (NASDAQ: AMPG), a state-of-the-art radio frequency (“RF”) signal component developer, has seen growing attention to its IP for satellite and 5G communications networks following its Nasdaq uplisting this year and its more recent inclusion on the Russell Microcap Index. “The company reported growth in its year-over-year and sequential quarterly revenues and gross profits when it released Q2 financial figures for the period ending June 30,” reads a recent article discussing AmpliTech’s performance. “The company also recently reported a Q2 2021 revenue of $1,024,410 signifying a 55% increase from Q2’20 revenue of $660,699. AmpliTech’s gross profits rose 52.5% to…

MondaySep 13, 2021 3:06 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Be Featured in ‘New to the Street’ Broadcast

InnerScope Hearing Technologies (OTC: INND) will be featured in an upcoming segment of FMW Media’s “New to the Street” nationally syndicated program. The company will be one of five featured on Tuesday, Sept. 14, 2021, with the broadcast airing at 10:30 p.m. PT on Fox Business Network. The segment will include another interview with INND CEO Matthew Moore, continuing to inform viewers about the company’s emerging and disruptive leadership in the “direct-to-consumer hearing technology” space. Moore explains his successful direct marketing strategy, helping provide consumers with the company’s hearing aids, selling at a fraction of the cost of those sold by the…

MondaySep 13, 2021 2:58 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first human clinical study showed the DehydraTECH-CBD compound was well tolerated by patients without troubling side effects and that the compound outperformed generic CBD controls Just-released initial (partial) results regarding the compound’s second human clinical trial show that a three-dose regimen…

MondaySep 13, 2021 2:48 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces Plans to Launch Products on Amazon Marketplace

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is in the process of launching as a seller on Amazon Marketplace. The company will be a seller on both the U.S. and Canadian sides of the online store well-recognized multinational e-commerce platform. According to the announcement, PlantX plans to utilize the Amazon Marketplace platform and back-end infrastructure to list and sell its plant-based items; the company will also use Amazon services to fulfill customer orders. As a seller, PlantX will have access to Amazon’s well-established fulfillment resources, customer service and extensive network of affiliates. “Launching on the Amazon platform is a great opportunity…

MondaySep 13, 2021 2:28 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Issue One-Time Special Dividend to Shareholders of Record

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will be issuing a one-time special dividend to shareholders of record on Sept. 20, 2021. The company reported Q2 revenue of $7.7M, up 557% year-over-year, 41% sequentially quarter-over-quarter, in addition to Q2 Sequire bookings of $11.4 million in its Q2 2021 earnings report. Following the report and exponential growth, SRAX also announced a $10 million stock buy-back program and a one-time special dividend to be issued to shareholders of record. SRAX will be issuing non-tradable…

MondaySep 13, 2021 2:05 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

So far in 2021, Tryp’s innovations have allowed it to position itself as a first-mover in the psychedelics space The company has announced completion of psychotherapy training for the upcoming phase 2a clinical trials for specific overeating disorders Tryp has also been keen on collaborating and partnering with key players in the industry, such as Calvert Labs and Gad Consulting services, the University of Michigan, and the University of Florida The company also understands the value of proper leadership and, so far in 2021, it has made strategic appointments to its board of directors Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF)…

MondaySep 13, 2021 2:01 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Recognition of Flora Beauty’s Mind Naturals as Trendsetting Brand at Cosmoprof North America

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that Flora Beauty recently participated in the 18th annual Cosmoprof North America (“CPNA”) event. At CPNA, Flora Beauty’s Mind Naturals CBD Rich Moisturizer was selected for its innovation and featured in CosmoTrends, a special section on the show floor and report on the most trendsetting products from CPNA exhibitors produced in collaboration with renowned international beauty trend forecasting authority BEAUTYSTREAMS. The highly anticipated CBD Beauty special area, featuring brands that contain CBD as an essential ingredient, made its debut as part…

MondaySep 13, 2021 1:43 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Empowering Pharmacists to Better Help Family Physicians and Patients

Through HealthTab, its flagship offering, Avricore turns pharmacies into community diagnostic centers by providing a turnkey point-of-care testing platform HealthTab is a multilayered operational ecosystem that provides endless possibilities, from lab-accurate tests to immediate results uploaded automatically on a web-based platform It enables patients to review the results on the spot with the pharmacist, allowing pharmacists to take on a more significant role in primary health services HealthTab ultimately aims to improve the quality of life for patients living with chronic illnesses A recent McKinsey article observed that consumers deeply care about wellness now more than ever; this interest is…

Site Search

Company Search